/Companies

Mariana Oncology

97 employees on LinkedIn · 10 known investors

Find your way into Mariana Oncology

Sign up to see every warm intro you have to Mariana Oncology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mariana Oncology team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue. Its pipeline targets challenging cancers with the goal of improving both treatment efficacy and patient experience.

Investors · 10

Also in the syndicate · 4

Deep Track CapitalleadEli LillyEli Lilly and CompanySurveyor Capital

Funding

SEC filings, press & company announcements

$175M disclosed across 1 of 2 rounds · 2021–2023

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Mariana Oncology went on to found or lead other companies.

In the news

Frequently asked questions

What does Mariana Oncology do?
Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue. Its pipeline targets challenging cancers with the goal of improving both treatment efficacy and patient experience.
Who are Mariana Oncology's investors?
Mariana Oncology's investors include Access Biotechnology, Atlas Venture, Nextech Invest, Access Industries, Forbion, RA Capital.
How much funding has Mariana Oncology raised?
Mariana Oncology has disclosed $175M raised across 1 of its 2 known rounds.